Literature DB >> 20737630

Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs.

Leonard Y Chu1, Seong-O Choi, Mark R Prausnitz.   

Abstract

Dissolving microneedle patches offer promise as a simple, minimally invasive method of drug and vaccine delivery to the skin that avoids the need for hypodermic needles. However, it can be difficult to control the amount and localization of drug within microneedles. In this study, we developed novel microneedle designs to improve control of drug encapsulation and delivery using dissolving microneedles by (i) localizing drug in the microneedle tip, (ii) increasing the amount of drug loaded in microneedles while minimizing wastage, and (iii) inserting microneedles more fully into the skin. Localization of our model drug, sulforhodamine B in the microneedle tip by either casting a highly concentrated polymer solution as the needle matrix or incorporating an air bubble at the base of the microneedle achieved approximately 80% delivery within 10 min compared to 20% delivery achieved by the microneedles encapsulating nonlocalized drug. As another approach, a pedestal was introduced to elevate each microneedle for more complete insertion into the skin and to increase its drug loading capacity by threefold from 0.018 to 0.053 microL per needle. Altogether, these novel microneedle designs provide a new set of tools to fabricate dissolving polymer microneedles with improved control over drug encapsulation, loading, and delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737630     DOI: 10.1002/jps.22140

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  48 in total

1.  Skin drug permeability and safety through a vibrating solid micro-needle system.

Authors:  Ting-Ting Liu; Kai Chen; Qiao Wang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Separable arrowhead microneedles.

Authors:  Leonard Y Chu; Mark R Prausnitz
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 3.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

4.  Transdermal delivery devices: fabrication, mechanics and drug release from silk.

Authors:  Waseem K Raja; Scott Maccorkle; Izzuddin M Diwan; Abdurrahman Abdurrob; Jessica Lu; Fiorenzo G Omenetto; David L Kaplan
Journal:  Small       Date:  2013-05-08       Impact factor: 13.281

5.  Assessment of mechanical stability of rapidly separating microneedles for transdermal drug delivery.

Authors:  Meng Chan He; Bo Zhi Chen; Mohammad Ashfaq; Xin Dong Guo
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

6.  Long-term stability of influenza vaccine in a dissolving microneedle patch.

Authors:  Matthew J Mistilis; Jessica C Joyce; E Stein Esser; Ioanna Skountzou; Richard W Compans; Andreas S Bommarius; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

7.  The maximum possible amount of drug in rapidly separating microneedles.

Authors:  Dan Dan Zhu; Xiao Peng Zhang; Chang Bing Shen; Yong Cui; Xin Dong Guo
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

Review 8.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

9.  Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; John W McBride; Cian M McCrudden; Eva M Vincente-Perez; Ryan F Donnelly; Helen O McCarthy
Journal:  Hum Vaccin Immunother       Date:  2016-11-15       Impact factor: 3.452

Review 10.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.